Related Experiment Video
Updated: Jul 24, 2025

Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry
Published on: January 26, 2024
Expert consensus on the integrated diagnosis of idiopathic multicentric Castleman disease
Santiago Montes-Moreno1, Fina Climent2, Máximo Fraga3
1Servicio de Anatomía Patológica y Laboratorio Hematopatología Traslacional, Hospital Universitario Marqués de Valdecilla/IDIVAL, Centro para la Investigación Biomédica CIBERONC, Santander, Spain.
Insights
Idiopathic multicentric Castleman disease (iMCD) diagnosis is standardized by expert consensus. This guide offers recommendations for integrated diagnosis, including clinical, lab, and imaging studies for histopathological confirmation.
Area of Science:
- Hematology
- Pathology
- Rheumatology
Background:
- Idiopathic multicentric Castleman disease (iMCD) is a rare systemic condition.
- Differential diagnosis includes inflammatory, autoimmune, and neoplastic disorders.
- Lymph node histopathology is crucial for diagnosing Castleman disease.
Purpose of the Study:
- To standardize the diagnosis of Castleman disease.
- To provide recommendations for the integrated diagnosis of iMCD.
- To establish guidelines for sample handling and result interpretation.
Main Methods:
- A multi-disciplinary consensus document was created by 53 experts from three medical societies (SEMI, SEHH, SEAP).
- The Delphi method was employed to reach consensus on diagnostic recommendations.
- Recommendations cover initial clinical, laboratory, and imaging studies.
Main Results:
- Specific recommendations for integrated iMCD diagnosis were developed.
- Guidelines for optimal sample acquisition for histopathology were established.
- Standardized procedures for laboratory testing and result reporting were defined.
Conclusions:
- Standardized diagnostic criteria and procedures are essential for iMCD.
- Expert consensus provides a framework for consistent and accurate diagnosis.
- This consensus aims to improve patient management through reliable diagnosis.
Abstract:
Idiopathic multicentric Castleman disease (iMCD) is rare. The differential diagnosis includes inflammatory, autoimmune and neoplastic disease. The identification of the histopathological features of Castleman disease in the lymph node is the main diagnostic criterion. Fifty-three experts from three medical societies (SEMI, SEHH and SEAP) have created a multi-disciplinary consensus document in order to standardise the diagnosis of Castleman disease. Using the Delphi method, specific recommendations for the initial clinical, laboratory and imaging studies have been made for an integrated diagnosis of iMCD as well as for the best way to obtain samples for histopathological confirmation, correct laboratory procedure and interpretation and reporting of results.
More Related Videos
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019